• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

scPharmaceuticals closes $46m Series B round

January 4, 2017 By Sarah Faulkner

scPharmaceuticals closes $46m Series B roundscPharmaceuticals said today that it closed a $45.6 million Series B round, co-led by OrbiMed and a subsidiary of Sun Pharmaceutical Industries. Other investors included 5AM Ventures and Lundbeckfond Ventures.

The investment will be used to support the development of the operational and commercial infrastructure needed to bring Furoscix and the sc2Wear Infusor to market in the U.S., the company said.

“We are very pleased with the strong interest in this financing round from leading life science and strategic corporate investors,” founder, president & CEO Dr. Pieter Muntendam said in prepared remarks. “The additional funds will support our preparation for the commercial introduction of Furoscix and the sc2Wear Infusor, as well as further development of our antibiotic pipeline products.”

The Lexington, Mass.-based company’s sc2Wear Infusor is a patch pump device that delivers drugs subcutaneously. scPharmaceutical’s lead products are the 1st subcutaneous formulations of furosemide, a parenteral diuretic to treat heart failure, and a widely used antibiotic known as ceftriaxone.

Jonathan Silverstein, partner & co-head of global private equity at OrbiMed, and Abhay Gandhi, CEO of North America at Sun Pharma, will join scPharmaceuticals’ board of directors as a part of the new financing.

“OrbiMed is pleased to participate in this financing of scPharmaceuticals,” Silverstein said. “The timing is right for the development of innovative life sciences products, such as the sc2Wear platform, which aim to reduce the overall cost of healthcare.”

Filed Under: Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals, Wall Street Beat Tagged With: scPharmaceuticals

IN CASE YOU MISSED IT

  • Medtronic to separate Diabetes business unit
  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS